Branwen Morgan

Branwen Morgan is a Visiting Professor at the University of Technology Sydney (UTS), Faculty of Science, and an Industry Associate Research Professor. She splits her role between UTS and the Future Industries Institute at the University of South Australia. Her primary affiliation is with the Australian Institute for Microbiology and Infection. She serves as Executive Officer and co-founder of OUTBREAK, a One Health decision support system addressing antibiotic resistance by integrating human, animal, plant, and environmental data. OUTBREAK involves 14 organizations across industry, academia, and end-users, funded by the Medical Research Future Fund.

Morgan’s research focuses on antimicrobial resistance (AMR), One Health frameworks, and the intersection of biotechnology, regulatory science, and public health policy. She has contributed to projects on nanoparticle therapies, point-of-care diagnostics, and sustainability in infection control. Her work emphasizes interdisciplinary collaboration and technology-driven solutions to global health challenges.

Professional memberships include the Australian Institute of Company Directors, Australian Society for Microbiology, and Science & Technology Australia’s Board (Technological Sciences Cluster Representative). Her funded research includes a UTS collaboration on antimicrobial resistance gene transfer in wastewater.